Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ZIDOVUDINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 3392 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Romano, L; Venturi, G; Vivarelli, A; Galli, L; Zazzi, M
      Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple

      CLINICAL INFECTIOUS DISEASES
    2. Devereux, HL; Burke, A; Lee, CA; Johnson, MA
      In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution

      JOURNAL OF MEDICAL VIROLOGY
    3. Cho, YK; Sung, H; Lee, HJ; Joo, CH; Cho, GJ
      Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed

      INTERNATIONAL IMMUNOPHARMACOLOGY
    4. Freund, YR; Dousman, L; Riccio, ES; Sato, B; MacGregor, JT; Mohagheghpour, N
      Immunohematotoxicity studies with combinations of dapsone and zidovudine

      INTERNATIONAL IMMUNOPHARMACOLOGY
    5. Olivero, OA; Reddy, MK; Pietras, SM; Poirier, MC
      Plasma drug levels compared with DNA incorporation of 3'-azido-3'-deoxythymidine (AZT) in adult cynomolgus (Macaca fascicularis) monkeys

      EXPERIMENTAL BIOLOGY AND MEDICINE
    6. Kim, S; Stair, EL; Lish, JW; Lochmiller, RL; Rafferty, DP; Qualls, CW
      Evaluation of myelotoxicity in cotton rats (Sigmodon hispidus) exposed to environmental contaminants. II. Myelotoxicity associated with petroleum industrial wastes

      JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A
    7. Akeb, F; Creminon, C; Grassi, J; Guedj, R; Duval, D
      The production and evaluation of antibodies for enzyme immunoassay of AZTTP

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    8. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
      Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    9. Skowron, G; Street, JC; Obee, EM
      Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    10. Hsu, LC; Vittinghoff, E; Katz, MH; Schwarcz, SK
      Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    11. Dunne, EF; Angoran-Benie, H; Kamelan-Tano, A; Sibailly, TS; Monga, BB; Kouadio, L; Roels, TH; Wiktor, SZ; Lackritz, EM; Mintz, ED; Luby, S
      Is drinking water in Abidjan, Cote d'Ivoire, safe for infant formula?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Meroni, L; Manganaro, D; Varchetta, S; Gatti, N; Riva, A; Monforte, AD; Galli, M
      Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    13. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    14. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    15. Monforte, AD; Bugarini, R; Pezzotti, P; De Luca, A; Antinori, A; Mussini, C; Vigevani, GM; Tirelli, U; Bruno, R; Gritti, F; Piazza, M; Chigiotti, S; Chirianni, A; De Stefano, C; Pizzigallo, E; Perrella, O; Moroni, M
      Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    16. Hossain, MM; Margolis, DM
      Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    17. Knobel, H; Miro, TM; Domingo, P; Rivero, A; Marquez, M; Force, L; Gonzalez, A; De Miguel, V; Sanz, J; Boix, V; Blanco, JL; Locutura, J
      Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: A double-blind placebo- controlled trial: The GESIDA 09/99 study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    18. Altice, FL; Mostashari, F; Friedland, GH
      Trust and the acceptance of and adherence to antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    19. Orloff, SL; Bulterys, M; Vink, P; Nesheim, S; Abrams, EJ; Schoenbaum, E; Palumbo, P; Steketee, RW; Simonds, RJ
      Maternal characteristics associated with antenatal, intrapartum, and neonatal zidovudine use in four US Cities, 1994-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    20. Fleishman, JA; Hellinger, FJ
      Trends in HIV-related inpatient admissions from 1993 to 1997: A seven-state study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    21. Manfredi, R
      A cross-sectional survey of HIV genotype mutations conferring resistance to all nonnucleoside reverse transcriptase inhibitors and related features, at the time of failure of antiretroviral therapy in the real world

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    22. Miller, MD; Margot, NA; Lamy, PD; Fuller, MD; Anton, KE; Mulato, AS; Cherrington, JM
      Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    23. Rey, D; Schmitt, MP; Partisani, M; Hess-Kempf, G; Krantz, W; de Mautort, E; Bernard-Henry, C; Priester, M; Cheneau, C; Lang, JM
      Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: A median follow-up of 64 weeks

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Blanch, J; Martinez, E; Rousaud, A; Blanco, JL; Garcia-Viejo, MA; Peri, JM; Mallolas, J; De Lazzari, E; De Pablo, J; Gatell, JM
      Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Easterbrook, PJ; Newson, R; Ives, N; Pereira, S; Moyle, G; Gazzard, BG
      Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Masquelier, B; Chaix, ML; Burgard, M; Lechenadec, J; Doussin, A; Simon, F; Cottalorda, J; Izopet, J; Tamalet, C; Douard, D; Fleury, H; Mayaux, MJ; Blanche, S; Rouzioux, C
      Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Lu, J; Kuritzkes, DR
      A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Sabin, CA; Fisher, M; Churchill, D; Pozniak, A; Hay, P; Easterbrook, P; Williams, I
      Long-term follow-up of antiretroviral-naive HIV-positive patients treated with nevirapine

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Pezzotti, P; Pappagallo, M; Phillips, PN; Boros, S; Valdarchi, C; Sinicco, A; Zaccarelli, M; Rezza, G
      Response to highly active antiretroviral therapy according to duration of HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Kost, RG; Hurley, A; Zhang, LQ; Vesanen, M; Talal, A; Furlan, S; Caldwell, P; Johnson, J; Smiley, L; Ho, D; Markowitz, M
      Open-label phase II trial of amprenavir, abacavir, and fixed-dose zidovudine/lamivudine in newly and chronically HIV-1-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
      Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Hansel, A; Bucher, HC; Nuesch, R; Battegay, H
      Reasons for discontinuation of first highly active antiretroviral therapy in a cohort of proteinase inhibitor-naive HIV-infected patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
      Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Kleeberger, CA; Phair, JP; Strathdee, SA; Detels, R; Kingsley, L; Jacobson, LP
      Determinants of heterogeneous adherence to HIV-antiretroviral therapies inthe multicenter AIDS cohort study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    41. Deeks, SG
      Nonnucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    42. Guay, LA
      From research to implementation: challenges in the prevention of mother tochild HIV transmission in the developing world

      TRENDS IN MOLECULAR MEDICINE
    43. Pereira, AS; Tidwell, RR
      Separation methods for nucleoside analogues used for treatment of HIV-1 infection

      JOURNAL OF CHROMATOGRAPHY B
    44. Zheng, JJ; Wu, ST; Emm, TA
      High-performance liquid chromatographic assay for the determination of 2 '-deoxy-3 '-thiacytidine (lamivudine) in human plasma

      JOURNAL OF CHROMATOGRAPHY B
    45. Clark, TN; White, CA; Chu, CK; Bartlett, MG
      Determination of 3 '-azido-2 ',3 '-dideoxyuridine in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    46. Fung, EN; Cai, ZW; Burnette, TC; Sinhababu, AK
      Simultaneous determination of Ziagen and its phosphorylated metabolites byion-pairing high-performance liquid chromatography-tandem mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    47. Holmes, W; Kwarteng, T
      Parent to child transmission of HIV: policy considerations in the Asia-Pacific region

      JOURNAL OF CLINICAL VIROLOGY
    48. Kamkamidze, G; Sullivan, T; Charbonneau, T
      Occurrence of HIV-1 reverse transcriptase gene mutation at codon 215 in HIV-infected infants

      JOURNAL OF CLINICAL VIROLOGY
    49. Savarino, A; Gennero, L; Sperber, K; Boelaert, JR
      The anti-HIV-1 activity of chloroquine

      JOURNAL OF CLINICAL VIROLOGY
    50. Berger, A; Preiser, W; Doerr, HW
      The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection

      JOURNAL OF CLINICAL VIROLOGY
    51. Mantovani, A; Calamandrei, G
      Delayed developmental effects following prenatal exposure to drugs

      CURRENT PHARMACEUTICAL DESIGN
    52. Pao, D; Watson, C; Peters, B; Lucas, SB; Miller, RF
      Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors

      SEXUALLY TRANSMITTED INFECTIONS
    53. McMahon, D; Lederman, M; Haas, DW; Haubrich, R; Stanford, J; Cooney, E; Horton, J; Kelleher, D; Ross, L; Cutrell, A; Lee, D; Spreen, W; Mellors, JW
      Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults

      ANTIVIRAL THERAPY
    54. Rozenbaum, W; Katlama, C; Massip, P; Bentata, M; Zucman, D; Delfraissy, JF; Trepo, C; David, F; Lanier, ER; Vavro, C; Mamet, JP
      Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment

      ANTIVIRAL THERAPY
    55. Kollmann, C; Tremblay, C; Giguel, F; Chou, TC; Hirsch, MS
      In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz

      ANTIVIRAL THERAPY
    56. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    57. Rusconi, S; Catamancio, SL; Citterio, P; Bulgheroni, E; Kurtagic, S; Galazzi, M; Croce, F; Moroni, M; Galli, M
      Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine

      ANTIVIRAL THERAPY
    58. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
      Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial

      ANTIVIRAL THERAPY
    59. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    60. Kijak, GH; Pampuro, SE; Avila, MM; Zala, C; Cahn, P; Wainberg, MA; Salomon, H
      Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina

      ANTIVIRAL THERAPY
    61. Pillay, D
      The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population

      ANTIVIRAL THERAPY
    62. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    63. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    64. Ebid, AHIM; Shelton, MJ; Adams, JM; Cordaro, JA; Gugino, LJ; Maliszewski, M; Colomaio, R; Hewitt, RG; Morse, GD
      Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women

      CLINICAL DRUG INVESTIGATION
    65. Caro, JJ; O'Brien, JA; Migliaccio-Walle, K; Raggio, G
      Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy

      PHARMACOECONOMICS
    66. D'Cruz, OJ; Uckun, FM
      Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3 '-azidothymidine-5 '-(p-bromophenyl) methoxyalaninyl phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice

      TOXICOLOGICAL SCIENCES
    67. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
      Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens

      JOURNAL OF HUMAN VIROLOGY
    68. Sothinathan, R; Briggs, WA; Eustace, JA
      Treatment of HIV-associated nephropathy

      AIDS PATIENT CARE AND STDS
    69. Buchanan, RJ; Wang, SJ; Huang, CF
      Nursing home residents with HIV and anemia

      AIDS PATIENT CARE AND STDS
    70. Kim, YK; Stoskopf, CH; Glover, SH
      Factors affecting total hospital charges and utilization for South Carolina inpatients with HTV/AIDS in 1994-1996

      AIDS PATIENT CARE AND STDS
    71. Knobel, H; Guelar, A; Carmona, A; Espona, M; Gonzalez, A; Lopez-Colomes, JL; Saballs, P; Gimeno, JL; Diez, A
      Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors

      AIDS PATIENT CARE AND STDS
    72. Tsasis, P
      Adherence assessment to highly active antiretroviral therapy

      AIDS PATIENT CARE AND STDS
    73. Parra, EO; Doran, TI; Ivy, LM; Aranda, JMR; Hernandez, C
      Concerns of pregnant women about being tested for HIV: A study in a predominately Mexican-American population

      AIDS PATIENT CARE AND STDS
    74. Dalakas, MC
      Peripheral neuropathy and antiretroviral drugs

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    75. Brown, BS; O'Grady, KE; Farrell, EV; Flechner, IS; Nurco, DN
      Factors associated with frequent and infrequent HIV testing

      SUBSTANCE USE & MISUSE
    76. Fan, B; Stewart, JT
      Determination of zidovudine/zalcitabine/nevirapine in human plasma by ion-pair HPLC

      JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
    77. Henderson, DK
      HIV postexposure prophylaxis in the 21st century

      EMERGING INFECTIOUS DISEASES
    78. Mitchell, W
      Neurological and developmental effects of HIV and AIDS in children and adolescents

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    79. Hatzakis, A; Gargalianos, P; Kiosses, V; Lazanas, M; Sypsa, V; Anastassopoulou, C; Vigklis, V; Sambatakou, H; Botsi, C; Paraskevis, D; Stalgis, C
      Low-dose IFN-alpha monotherapy in treatment-naive individuals with HIV-1 infection: Evidence of potent suppression of viral replication

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    80. Wolf, LE; Lo, B; Beckerman, KP; Dorenbaum, A; Kilpatrick, S; Weintrub, PS
      When parents reject interventions to reduce postnatal human immunodeficiency virus transmission

      ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    81. Babl, FE; Cooper, ER; Kastner, B; Kharasch, S
      Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents

      ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
    82. Candal, D; Bulterys, M; Abrams, EJ; Steketee, RW; Parekh, BS
      Efficacy of a less-sensitive enzyme immunoassay (3A11-LS) for early diagnosis of human immunodeficiency virus type 1 infection in infants

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    83. Warner, JEA; Ries, KM
      Optic neuropathy in a patient with AIDS

      JOURNAL OF NEURO-OPHTHALMOLOGY
    84. Rayner, CR; Esch, LD; Wynn, HE; Eales, R
      Symptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimen

      ANNALS OF PHARMACOTHERAPY
    85. Arnsten, JH; Demas, PA; Farzadegan, H; Grant, RW; Gourevitch, MN; Chang, CJ; Buono, D; Eckholdt, H; Howard, AA; Schoenbaum, EE
      Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring

      CLINICAL INFECTIOUS DISEASES
    86. Duong, M; Piroth, L; Peytavin, G; Forte, F; Kohli, E; Grappin, M; Buisson, M; Chavanet, P; Portier, H
      Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response

      CLINICAL INFECTIOUS DISEASES
    87. Delgado, J; Harris, M; Tesiorowski, A; Montaner, JSG
      Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: A case series

      CLINICAL INFECTIOUS DISEASES
    88. Bersoff-Matcha, S; Miller, W; Mundy, LM
      Sex differences in nevirapine rash - Reply

      CLINICAL INFECTIOUS DISEASES
    89. Coghlan, ME; Sommadossi, JP; Jhala, NC; Many, WJ; Saag, MS; Johnson, VA
      Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases

      CLINICAL INFECTIOUS DISEASES
    90. Sitnitskaya, Y; Rochford, G; Rigaud, M; Essajee, S; Pollack, H; Krasinski, K; Borkowsky, W
      Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995-1999

      CLINICAL INFECTIOUS DISEASES
    91. Szczech, LA
      Renal diseases associated with human immunodeficiency virus infection: Epidemiology, clinical course, and management

      CLINICAL INFECTIOUS DISEASES
    92. Hanna, GJ; D'Aquila, RT
      Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

      CLINICAL INFECTIOUS DISEASES
    93. Cunningham, CK; Wara, DW; Kang, MH; Fenton, T; Hawkins, E; McNamara, J; Mofenson, L; Duliege, AM; Francis, D; McFarland, EJ; Borkowsky, W
      Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women

      CLINICAL INFECTIOUS DISEASES
    94. Phillips, P
      Immunoresititution disease in relation to infection with Mycobacterium avium complex and to leprosy

      CLINICAL INFECTIOUS DISEASES
    95. Cheng, VCC; Yuen, KY
      Immunoresititution disease in relation to infection with Mycobacterium avium complex and to leprosy - Reply

      CLINICAL INFECTIOUS DISEASES
    96. Saulsbury, FT
      Resolution of organ-specific complications of human immunodeficiency virusinfection in children with use of highly active antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    97. French, MA; Price, P
      Immune restoration disease in HIV-infected patients after antiretroviral therapy

      CLINICAL INFECTIOUS DISEASES
    98. Bersoff-Matcha, SJ; Miller, WC; Aberg, JA; van der Horst, C; Hamrick, HJ; Powderly, WG; Mundy, LM
      Sex differences in nevirapine rash

      CLINICAL INFECTIOUS DISEASES
    99. Avants, SK; Margolin, A; Warburton, LA; Hawkins, KA; Shi, J
      Predictors of nonadherence to HIV-related medication regimens during methadone stabilization

      AMERICAN JOURNAL ON ADDICTIONS
    100. White, JD; Wharfe, G; Stewart, DM; Maher, VE; Eicher, D; Herring, B; Derby, M; Jackson-Booth, PG; Marshall, M; Lucy, D; Jain, A; Cranston, B; Hanchard, B; Lee, CC; Top, LE; Fleisher, TA; Nelson, DL; Waldmann, TA
      The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma

      LEUKEMIA & LYMPHOMA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 11:31:28